Measured Wealth Private Client Group’s Lifestance Health LFST Stock Holding History

Measured Wealth Private Client Group’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.9K	Buy	+1,485	New	+$11.5K	﹤0.01%	530

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Measured Wealth Private Client Group's LFST Position: Q2 2026 in Review

Measured Wealth Private Client Group opened a new position in Lifestance Health (LFST) in Q2 2026: 1,485 shares worth $15.9K. The stake represents ﹤0.01% of the portfolio and ranks #530 among its holdings.

287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

Measured Wealth Private Client Group held 1,485 shares of Lifestance Health worth $15.9K as of Q2 2026.
Lifestance Health was a new Measured Wealth Private Client Group position in Q2 2026.
Lifestance Health made up ﹤0.01% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #530 holding.
287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.